| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,095,555 ) |
| | 2025 | 2025 | MERCATOR MEDSYSTEMS, INC. | 520 MCCORMICK ST | SAN LEANDRO | CA | 94577-1108 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 5 | NIH | 3/7/2025 | $1,000,000 |
| | 2025 | 2025 | MERCATOR MEDSYSTEMS, INC. | 520 MCCORMICK ST | SAN LEANDRO | CA | 94577-1108 | ALAMEDA | USA | R44HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 000 | 3 | NIH | 8/4/2025 | $1,095,555 |
|
| Issue Date FY: 2024 ( Subtotal = $2,636,379 ) |
| | 2024 | 2024 | MERCATOR MEDSYSTEMS, INC. | 520 MCCORMICK ST | SAN LEANDRO | CA | 94577-1108 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 4 | NIH | 12/29/2023 | $1,000,000 |
| | 2024 | 2024 | MERCATOR MEDSYSTEMS, INC. | 520 MCCORMICK ST | SAN LEANDRO | CA | 94577-1108 | ALAMEDA | USA | R44HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 000 | 2 | NIH | 9/18/2024 | $1,636,379 |
| | 2024 | 2021 | MERCATOR MEDSYSTEMS, INC. | 520 MCCORMICK ST | SAN LEANDRO | CA | 94577-1108 | ALAMEDA | USA | R41HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 000 | 1 | NIH | 1/19/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R41HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 000 | 1 | NIH | 11/12/2021 | $0 |
| | 2022 | 2021 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R41HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 001 | 1 | NIH | 7/7/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $299,678 ) |
| | 2021 | 2021 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R41HL160434 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery | 000 | 1 | NIH | 9/20/2021 | $299,678 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2014 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 3 | NIH | 7/11/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = -$120 ) |
| | 2017 | 2014 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 3 | NIH | 8/1/2017 | $0 |
| | 2017 | 2013 | MERCATOR MEDSYSTEMS, INC. | 1900 POWELL ST STE 800 | EMERYVILLE | CA | 94608-1813 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 3/9/2017 | -$120 |
|
| Issue Date FY: 2016 ( Subtotal = $0 ) |
| | 2016 | 2014 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 3 | NIH | 5/31/2016 | $0 |
| | 2016 | 2012 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 4/18/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2013 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 9/18/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $1,088,602 ) |
| | 2014 | 2014 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 3 | NIH | 4/23/2014 | $1,088,602 |
| | 2014 | 2013 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 9/5/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $1,173,555 ) |
| | 2013 | 2013 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 9/13/2013 | $213,437 |
| | 2013 | 2013 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R44HL102998 | Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease | 000 | 2 | NIH | 7/15/2013 | $960,118 |
|
| Issue Date FY: 2012 ( Subtotal = $463,075 ) |
| | 2012 | 2012 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 3 | NIH | 9/12/2012 | $463,075 |
|
| Issue Date FY: 2011 ( Subtotal = $676,092 ) |
| | 2011 | 2011 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R42CA141907 | Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma | 000 | 2 | NIH | 9/23/2011 | $676,092 |
|
| Issue Date FY: 2010 ( Subtotal = $217,409 ) |
| | 2010 | 2010 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R43HL102998 | IMPROVED ADVENTITIAL SIROLIMUS THERAPY FOR PERIPHERAL ARTERY RESTENOSIS | 000 | 1 | NIH | 8/9/2010 | $217,409 |
|
| Issue Date FY: 2009 ( Subtotal = $218,055 ) |
| | 2009 | 2009 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577-5720 | ALAMEDA | USA | R41CA141907 | BRONCHIO-ADVENTITIAL DRUG DELIVERY: PACLITAXEL FOR BRONCHIAL CARCINOMA | 000 | 1 | NIH | 9/11/2009 | $218,055 |
|
| Issue Date FY: 2007 ( Subtotal = $194,215 ) |
| | 2007 | 2007 | MERCATOR MEDSYSTEMS INC | 3077 TEAGARDEN STREET | SAN LEANDRO | CA | 94577 | ALAMEDA | USA | R43DK077552 | ADVENTITIAL PACLITAXEL TO DELAY POST-INTERVENTION DIALYSIS GRAFT STENOSIS | 000 | 1 | NIH | 9/18/2007 | $194,215 |
|
|
